As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.
The death toll from the 2019-nCoV coronavirus in China has now risen to 106 people, with confirmed infections growing to more than 4,500. Cases have also been confirmed in Japan, Hong Kong, Macau, South Korea, Taiwan, Thailand, the US, Germany and France. Despite this alarming rise in cases, the head of the World Health Organization Tedros Adhanom Ghebreyesus has said he is confident that China can contain the outbreak. It has, for now, stopped short of declaring it an international emergency, but could do so if the virus’s spread is not held back.
Johnson & Johnson’s Janssen division and a parallel effort led by new public-private coalition which have been fastest to respond.






